Management of defecation disorders with botulinum neurotoxin.
Brisinda
G
G
Cadeddu
F
F
Brandara
F
F
Maria
G
G
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D002400:Cathartics / Q000627:therapeutic use*; D003248:Constipation / Q000188:drug therapy*; D006801:Humans
D018726:Anti-Dyskinesia Agents; D002400:Cathartics; D001905:Botulinum Toxins